MedTrace Logo

Profiling Neutrophil Counts in Patients on Chemotherapy

NCT02806557 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2016-08-01

No results posted yet for this study

Summary

The purpose of this trial is to observe the changes in white cell counts in patients with cancer during chemotherapy and to determine if changes in the white cell count in the early days during chemotherapy can be used as a predictor of severe neutropenia and its complications.

Conditions

Interventions

DEVICE

Home finger-prick capillary blood count monitoring

A nurse will visit the participant's home according to the test schedule (up to a maximum frequency of 21 visits in a 21-day cycle) and perform the finger-prick capillary blood test and measure the neutrophil count using the Hemocue® WBC DIFF device.

Sponsors & Collaborators

  • Philips Healthcare

    collaborator INDUSTRY

  • University of Leeds

    lead OTHER

Principal Investigators

  • Geoff Hall, FRCP, PhD · University of Leeds

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2018-03-31
Completion
2018-03-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02806557 on ClinicalTrials.gov